


{"id":49466,"date":"2023-09-21T12:05:54","date_gmt":"2023-09-21T10:05:54","guid":{"rendered":"https:\/\/www.fyb.de\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/"},"modified":"2023-09-27T12:07:22","modified_gmt":"2023-09-27T10:07:22","slug":"gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/","title":{"rendered":"Gibson Dunn advises Eurazeo on financing of LRE Medical acquisition by Gyrus Capital"},"content":{"rendered":"<p>Frankfurt\/ N\u00f6rd\u00adlin\u00adgen \u2014 Gibson, Dunn &amp; Crut\u00adcher LLP advi\u00adsed Eura\u00adzeo Invest\u00adment Mana\u00adger S.A. in connec\u00adtion with the finan\u00adcing of the acqui\u00adsi\u00adtion of LRE Medi\u00adcal GmbH by Gyrus Capi\u00adtal. The parties have agreed not to disc\u00adlose details of the transaction.<\/p>\n<p><strong>Eura\u00adzeo<\/strong> is a leading global invest\u00adment company listed on the Euron\u00adext Paris Stock Exch\u00adange. Through its Direct Lending team, it provi\u00addes flexi\u00adble senior and subor\u00addi\u00adna\u00adted finan\u00adcing for acqui\u00adsi\u00adti\u00adons and Euro\u00adpean SMEs with a valua\u00adtion between EUR 30 million and EUR 300 million.<\/p>\n<p><strong>LRE Medi\u00adcal<\/strong>, head\u00adquar\u00adte\u00adred in N\u00f6rd\u00adlin\u00adgen, Germany, supports its global custo\u00admer base with a compre\u00adhen\u00adsive service offe\u00adring that provi\u00addes high-quality tech\u00adni\u00adcal solu\u00adti\u00adons and manu\u00adfac\u00adtu\u00adring of medi\u00adcal and life science diagno\u00adstic equip\u00adment. LRE Medi\u00adcal was foun\u00added in 1961 and employs more than 250 people at two loca\u00adti\u00adons in Germany.<\/p>\n<p><strong>Gyrus Capi\u00adtal<\/strong> is a Euro\u00adpean invest\u00adment firm specia\u00adli\u00adzing in trans\u00adfor\u00adma\u00adtive invest\u00adments in health and sustaina\u00adbi\u00adlity. Based in Geneva, Switz\u00ader\u00adland, Gyrus invests in compa\u00adnies that address struc\u00adtu\u00adral needs of society and the envi\u00adron\u00adment and are focu\u00adsed on long-term, sustainable growth. Gyrus focu\u00adses on complex tran\u00adsac\u00adtions with a parti\u00adcu\u00adlar empha\u00adsis on corpo\u00adrate spin-offs and busi\u00adness succes\u00adsi\u00adons in the \u20ac50 million to \u20ac500 million range.<\/p>\n<p>The<strong> Gibson Dunn<\/strong> team, led by Frank\u00adfurt finance part\u00adner <strong>Sebas\u00adtian Schoon<\/strong> (\u00a9 Gibson Dunn), included finance coun\u00adsel Alex\u00adan\u00adder Klein and finance asso\u00adciate Bastiaan Wolters (both Frankfurt).<\/p>\n<p><strong>About Gibson Dunn<\/strong><br>\nGibson, Dunn &amp; Crut\u00adcher LLP is one of the leading inter\u00adna\u00adtio\u00adnal law firms and is ranked among the top law firms world\u00adwide in indus\u00adtry surveys and by autho\u00adri\u00adta\u00adtive publi\u00adca\u00adti\u00adons. With more than 1,800 lawy\u00aders in 20 offices, the firm has a global presence in all major econo\u00admic regi\u00adons. Gibson Dunn offices are loca\u00adted in Abu Dhabi, Brussels, Century City, Dallas, Denver, Dubai, Frank\u00adfurt, Hong Kong, Hous\u00adton, London, Los Ange\u00adles, Munich, New York, Orange County, Palo Alto, Paris, Beijing, San Fran\u00adcisco, Singa\u00adpore and Washing\u00adton, D.C. For more infor\u00adma\u00adtion, visit www.gibsondunn.com.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frankfurt\/ N\u00f6rd\u00adlin\u00adgen \u2014 Gibson, Dunn &amp; Crut\u00adcher LLP advi\u00adsed Eura\u00adzeo Invest\u00adment Mana\u00adger S.A. in connec\u00adtion with the finan\u00adcing of the acqui\u00adsi\u00adtion of LRE Medi\u00adcal GmbH by Gyrus Capi\u00adtal. The parties have agreed not to disc\u00adlose details of the tran\u00adsac\u00adtion. Eura\u00adzeo is a leading global invest\u00adment company listed on the Euron\u00adext Paris Stock Exch\u00adange. Through its&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":49464,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1367,1368,1369,2635],"tags":[],"class_list":["post-49466","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-investors","category-corporate-finance-mergers-acquisitions-en-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Gibson Dunn advises Eurazeo on financing of LRE Medical acquisition by Gyrus Capital - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gibson Dunn advises Eurazeo on financing of LRE Medical acquisition by Gyrus Capital - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Frankfurt\/ N\u00f6rd\u00adlin\u00adgen \u2014 Gibson, Dunn &amp; Crut\u00adcher LLP advi\u00adsed Eura\u00adzeo Invest\u00adment Mana\u00adger S.A. in connec\u00adtion with the finan\u00adcing of the acqui\u00adsi\u00adtion of LRE Medi\u00adcal GmbH by Gyrus Capi\u00adtal. The parties have agreed not to disc\u00adlose details of the transaction. Eura\u00adzeo is a leading global invest\u00adment company listed on the Euron\u00adext Paris Stock Exch\u00adange. Through its [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-21T10:05:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-27T10:07:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/09\/sebastian-schoon-gibson-dunn-e1695809055868.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Gibson Dunn advises Eurazeo on financing of LRE Medical acquisition by Gyrus Capital\",\"datePublished\":\"2023-09-21T10:05:54+00:00\",\"dateModified\":\"2023-09-27T10:07:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/\"},\"wordCount\":318,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/09\/sebastian-schoon-gibson-dunn-e1695809055868.jpg\",\"articleSection\":[\"General\",\"Featured\",\"Private equity\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Lawyers, tax consultants, auditors\",\"Investors\",\"corporate-finance-mergers-acquisitions-en\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/\",\"url\":\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/\",\"name\":\"Gibson Dunn advises Eurazeo on financing of LRE Medical acquisition by Gyrus Capital - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/09\/sebastian-schoon-gibson-dunn-e1695809055868.jpg\",\"datePublished\":\"2023-09-21T10:05:54+00:00\",\"dateModified\":\"2023-09-27T10:07:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/09\/sebastian-schoon-gibson-dunn-e1695809055868.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/09\/sebastian-schoon-gibson-dunn-e1695809055868.jpg\",\"width\":300,\"height\":330},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gibson Dunn advises Eurazeo on financing of LRE Medical acquisition by Gyrus Capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gibson Dunn advises Eurazeo on financing of LRE Medical acquisition by Gyrus Capital - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/","og_locale":"en_US","og_type":"article","og_title":"Gibson Dunn advises Eurazeo on financing of LRE Medical acquisition by Gyrus Capital - FYB Financial Yearbook","og_description":"Frankfurt\/ N\u00f6rd\u00adlin\u00adgen \u2014 Gibson, Dunn &amp; Crut\u00adcher LLP advi\u00adsed Eura\u00adzeo Invest\u00adment Mana\u00adger S.A. in connec\u00adtion with the finan\u00adcing of the acqui\u00adsi\u00adtion of LRE Medi\u00adcal GmbH by Gyrus Capi\u00adtal. The parties have agreed not to disc\u00adlose details of the transaction. Eura\u00adzeo is a leading global invest\u00adment company listed on the Euron\u00adext Paris Stock Exch\u00adange. Through its [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2023-09-21T10:05:54+00:00","article_modified_time":"2023-09-27T10:07:22+00:00","og_image":[{"width":300,"height":330,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/09\/sebastian-schoon-gibson-dunn-e1695809055868.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Gibson Dunn advises Eurazeo on financing of LRE Medical acquisition by Gyrus Capital","datePublished":"2023-09-21T10:05:54+00:00","dateModified":"2023-09-27T10:07:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/"},"wordCount":318,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/09\/sebastian-schoon-gibson-dunn-e1695809055868.jpg","articleSection":["General","Featured","Private equity","News","Lawyers\/Tax-advisors\/Auditors","Lawyers, tax consultants, auditors","Investors","corporate-finance-mergers-acquisitions-en"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/","url":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/","name":"Gibson Dunn advises Eurazeo on financing of LRE Medical acquisition by Gyrus Capital - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/09\/sebastian-schoon-gibson-dunn-e1695809055868.jpg","datePublished":"2023-09-21T10:05:54+00:00","dateModified":"2023-09-27T10:07:22+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/09\/sebastian-schoon-gibson-dunn-e1695809055868.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/09\/sebastian-schoon-gibson-dunn-e1695809055868.jpg","width":300,"height":330},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/gibson-dunn-advises-eurazeo-on-financing-and-acquisition-of-lre-medical-by-gyrus-capital\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Gibson Dunn advises Eurazeo on financing of LRE Medical acquisition by Gyrus Capital"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/49466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=49466"}],"version-history":[{"count":2,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/49466\/revisions"}],"predecessor-version":[{"id":49469,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/49466\/revisions\/49469"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/49464"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=49466"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=49466"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=49466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}